Thrombocytopenia differential diagnosis: Difference between revisions
Line 666: | Line 666: | ||
|- | |- | ||
! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection-induced | ! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection-induced | ||
! rowspan="3" align="center" style="background:#DCDCDC;" + |Bacterial infections | ! rowspan="3" align="center" style="background:#DCDCDC;" + |[[Infection|Bacterial infections]] | ||
! align="center" style="background:#DCDCDC;" + |Sepsis | ! align="center" style="background:#DCDCDC;" + |[[Sepsis]] | ||
| align="center" style="background:#F5F5F5;" + |Direct bone marrow suppression | | align="center" style="background:#F5F5F5;" + |Direct bone marrow suppression | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 697: | Line 697: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Helicobacter pylori | ! align="center" style="background:#DCDCDC;" + |[[Helicobacter pylori]] | ||
| align="center" style="background:#F5F5F5;" + |Immune thrombocytopenia | | align="center" style="background:#F5F5F5;" + |Immune thrombocytopenia | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 727: | Line 727: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Tick-borne infection | ! align="center" style="background:#DCDCDC;" + |[[Tick-borne disease|Tick-borne infection]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 757: | Line 757: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#DCDCDC;" + |Viral infections | ! rowspan="2" align="center" style="background:#DCDCDC;" + |[[Virus|Viral infections]] | ||
! align="center" style="background:#DCDCDC;" + |HIV | ! align="center" style="background:#DCDCDC;" + |[[Human Immunodeficiency Virus (HIV)|HIV]] | ||
| align="Left" style="background:#F5F5F5;" + | | | align="Left" style="background:#F5F5F5;" + |An ITP-like condition called primary HIV-associated thrombocytopenia | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 791: | Line 788: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | ! align="center" style="background:#DCDCDC;" + |Other viruses such as [[rubella]], [[mumps]], [[varicella]], [[parvovirus]], [[hepatitis C]], & [[Epstein Barr virus|Epstein-Barr virus]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 821: | Line 818: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#DCDCDC;" + | | ! rowspan="2" align="center" style="background:#DCDCDC;" + |[[Parasitism|Parasitic infections]] | ||
! align="center" style="background:#DCDCDC;" + |Malaria | ! align="center" style="background:#DCDCDC;" + |[[Malaria]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 852: | Line 849: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Babesiosis | ! align="center" style="background:#DCDCDC;" + |[[Babesiosis]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 915: | Line 912: | ||
|- | |- | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity | ||
! align="center" style="background:#DCDCDC;" + | | ! align="center" style="background:#DCDCDC;" + |[[Antibiotic|Antibiotics]]/ | ||
[[Anticonvulsant|Antiepileptic]] | |||
! align="left" style="background:#DCDCDC;" + | | ! align="left" style="background:#DCDCDC;" + | | ||
* | * [[Quinine]] | ||
* | * [[Sulfonamide (medicine)|Sulfonamides]] | ||
* | * [[Carbamazepine]] | ||
* [[Phenytoin]] | |||
| align="center" style="background:#F5F5F5;" + |Occurrence of drug-dependent, platelet-reactive [[antibodies]] | |||
* | |||
| align="center" style="background:#F5F5F5;" + |Occurrence of drug-dependent, platelet-reactive antibodies | |||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 956: | Line 948: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Heparin-induced thrombocytopenia | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Heparin-induced thrombocytopenia]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 986: | Line 978: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Cytotoxic chemotherapy | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Chemotherapy|Cytotoxic chemotherapy]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 1,016: | Line 1,008: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Radiation therapy | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Radiation therapy]] | ||
| align="center" style="background:#F5F5F5;" + |Predictable, dose-dependent myelosuppression | | align="center" style="background:#F5F5F5;" + |Predictable, dose-dependent [[Bone marrow suppression|myelosuppression]] | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,046: | Line 1,038: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |OTC agents | ! align="center" style="background:#DCDCDC;" + |[[Over-the-counter drug|OTC agents]] | ||
! align="center" style="background:#DCDCDC;" + |Quinine-containing beverages | ! align="center" style="background:#DCDCDC;" + |[[Quinine]]-containing beverages | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,078: | Line 1,070: | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Chronic liver disease | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Chronic liver disease]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 1,108: | Line 1,100: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Portal hypertension | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Portal hypertension]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | |
Revision as of 15:43, 15 August 2018
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia differential diagnosis On the Web |
American Roentgen Ray Society Images of Thrombocytopenia differential diagnosis |
Risk calculators and risk factors for Thrombocytopenia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D.
Overview
Thrombocytopenia has a broad range of potential causes. While a good history and physical examination can be helpful to diagnose some of these causes such as drug-induced thrombocytopenia, they usually don't suffice and further evaluation is often needed. There are also some useful points that may guide the physician to an appropriate diagnosis. For example, asymptomatic, isolated thrombocytopenia most probably suggests ITP, while thrombocytopenia in critically ill, hospitalized patients is usually suggestive of iatrogenic causes (eg. dilution), platelet consumption, bone marrow suppression from infection/sepsis, or even drug-induced thrombocytopenia. One should consider however, that a wide variety of other conditions such as autoimmune disorders, nutrient deficiencies, thrombotic microangiopathies could all as well cause thrombocytopenia.
Thrombocytopenia Differential Diagnosis
Differentiating the diseases that can cause thrombocytopenia:
Category | Condition | Mechanism | Mechanism | Inherited | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age range | History | Symptoms | Signs | |||||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||||
Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | BT | UA | ||||||||||||||||
Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Plt | HB | WBC | |||||||||||||||||||||||||
Hematology | Bone marrow disorders | Myelodysplastic syndromes | + | |||||||||||||||||||||||||||
Aplastic anemia | + | |||||||||||||||||||||||||||||
Acute leukemia | + | |||||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | + | |||||||||||||||||||||||||||||
Thrombotic microangiopathy (TMA) | Thrombotic thrombocytopenic purpura (TTP) | + | ||||||||||||||||||||||||||||
Hemolytic uremic syndrome (HUS) | + | |||||||||||||||||||||||||||||
DIC | + | |||||||||||||||||||||||||||||
Congenital platelet disorders | MYH-9 related disorders | |||||||||||||||||||||||||||||
Bernard-Soulier syndrome | ||||||||||||||||||||||||||||||
Gray platelet syndrome | ||||||||||||||||||||||||||||||
Wiskott-Aldrich syndrome | ||||||||||||||||||||||||||||||
Thrombocytopenia with absent radius (TAR) syndrome | ||||||||||||||||||||||||||||||
Alport syndrome | ||||||||||||||||||||||||||||||
Von Willebrand disease | ||||||||||||||||||||||||||||||
Nutrient deficiencies | Folate, vitamin B12, copper | + | ||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Rheumatologic/autoimmune disorders | Immune thrombocytopenia | Antibody-mediated platelet destruction | + | |||||||||||||||||||||||||||
Systemic lupus erythematosus (SLE) | + | |||||||||||||||||||||||||||||
Antiphospholipid syndrome (APS) | Autoantibody-mediated syndrome | + | ||||||||||||||||||||||||||||
Felty's syndrome | Splenomegaly | + | ||||||||||||||||||||||||||||
Infection-induced | Bacterial infections | Sepsis | Direct bone marrow suppression | + | + | ↑ | ↑ | |||||||||||||||||||||||
Helicobacter pylori | Immune thrombocytopenia | + | ||||||||||||||||||||||||||||
Tick-borne infection | + | |||||||||||||||||||||||||||||
Viral infections | HIV | An ITP-like condition called primary HIV-associated thrombocytopenia | + | + | + | |||||||||||||||||||||||||
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | + | |||||||||||||||||||||||||||||
Parasitic infections | Malaria | |||||||||||||||||||||||||||||
Babesiosis | ||||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Medication/toxicity | Antibiotics/ | Occurrence of drug-dependent, platelet-reactive antibodies | + | + | ||||||||||||||||||||||||||
Heparin-induced thrombocytopenia | + | |||||||||||||||||||||||||||||
Cytotoxic chemotherapy | + | |||||||||||||||||||||||||||||
Radiation therapy | Predictable, dose-dependent myelosuppression | + | ||||||||||||||||||||||||||||
OTC agents | Quinine-containing beverages | |||||||||||||||||||||||||||||
GI | Chronic liver disease | + | ||||||||||||||||||||||||||||
Portal hypertension | ||||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Vascular | Giant capillary hemangioma | Platelet destruction | + | |||||||||||||||||||||||||||
Aortic aneurysm | Platelet destruction | + | ||||||||||||||||||||||||||||
Cardiopulmonary bypass | Platelet destruction | + | ||||||||||||||||||||||||||||
Other | Alcohol | + | ||||||||||||||||||||||||||||
Post-transfusion purpura | Immune mediated platelet destruction | + | ||||||||||||||||||||||||||||
Gestational thrombocytopenia | ||||||||||||||||||||||||||||||
HELLP syndrome |